SCHEMBL10062341

SCHEMBL10062341

c1ccc2c(c1)ccc1c2nc2ccccn21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 6/20 0.47
GLA P06280 5/20 0.47
GAA P10253 5/20 0.47
NPC1 O15118 4/20 0.47
HSD17B10 Q99714 4/20 0.47
HPGD P15428 3/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
PARP1 P09874 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
RAB9A P51151 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
TP53 P04637 1/20 0.44
MAPK10 P53779 1/20 0.44
POLB P06746 2/20 0.44
MAPT P10636 1/20 0.44
NPSR1 Q6W5P4 1/20 0.42
GABRA1 P14867 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30966873 1.00 KDM4E (0.47) KDM4EALDH1A1GLAGAANPC1
SCHEMBL23533799 0.92 PARP1 (0.47) KDM4EALDH1A1GLAGAANPC1
SCHEMBL31195892 0.76 TLR8 (0.38) ALDH1A1GAANPC1HSD17B10PARP1
SCHEMBL1650122 0.76 KDM4E (0.41) KDM4EALDH1A1GLAGAANPC1
SCHEMBL21656372 0.75 RAB9A (0.40) KDM4EALDH1A1GLAGAANPC1
SCHEMBL14929656 0.75 TLR7 (0.49) KDM4EALDH1A1GLAGAANPC1
SCHEMBL18721046 0.73 DRD1 (0.40) KDM4EALDH1A1GAANPC1HSD17B10
SCHEMBL21622755 0.73 GABRA1 (0.64) KDM4EALDH1A1GLAGAANPC1
SCHEMBL21622880 0.73 KDM4E (0.53) KDM4EALDH1A1GLAGAANPC1
SCHEMBL13852951 0.73 CYP2A6 (0.44) ALDH1A1NPC1HSD17B10RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170324046-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-11-09 US disclosed
US-9382253-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-07-05 US disclosed
US-9382253-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-07-05 US disclosed
US-9382253-B2 Metal complexes MERCK PATENT GMBH (DE) 2016-07-05 US disclosed
US-20130112921-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130112921-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
US-20130112921-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-05-09 US disclosed
WO-2012007087-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130112921-A1 METAL COMPLEXES MCOLN2, MCOLN1, NCLN KDM4E 3819/4885ALDH1A1 3236/4885GLA 3458/4885
US-20170324046-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 KDM4E 1752/4885ALDH1A1 953/4885GLA 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.